1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > In Vitro Diagnostics Analysis & Statistics

In Vitro Diagnostics Analysis & Statistics

Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

Publishers

  • All
    • Kalorama Information

All regions

data types

1-6 of 6 reports

Immunoassays Markets

  • $ 4500
  • September 2017
  • 470 pages

This report, from Kalorama Information, the premier market research publisher in in vitro diagnostics, features the following market data: - Global Immunoassay Market, 2017-2021 - Historical Market 2014-2016 ...

  • Diagnostics
  • Immunodiagnostics
  • In Vitro Diagnostics
  • Infectious Disease
  • Company

The Top 50 Companies in Point-Of-Care Diagnostics

  • $ 3500
  • May 2017
  • 179 pages

The POC market is considered evolving with growthopportunity.   Developing and developedmarkets alike have room to grow due to an aging population worldwide.  Key companies such as Roche, LifeScan,Abbott, ...

  • Diagnostics
  • In Vitro Diagnostics
  • Point Of Care Testing
  • Company
  • Beckman Coulter, Inc.

Top 50 Companies in Point-of-Care Diagnostic Testing

  • $ 3500
  • May 2017
  • 179 pages

The POC market is considered evolving with growthopportunity.   Developing and developedmarkets alike have room to grow due to an aging population worldwide.  Key companies such as Roche, LifeScan,Abbott, ...

  • Diagnostics
  • In Vitro Diagnostics
  • Point Of Care Testing
  • World
  • Company

Mergers and Acquisitions in the IVD Market

  • $ 995
  • January 2017
  • 60 pages

Mergers and Acquisitions in the IVD Market Mergers and Acquisitions (M&A) activity in the in vitro diagnostics (IVD) market was brisk in 2016. Kalorama's report records 250 acquisitions in the industry ...

  • Diagnostics
  • In Vitro Diagnostics
  • M&A

Cardiac Markers

  • $ 1995
  • June 2016
  • 71 pages

Cardiac Markers provides market assessment, estimate and competitive analysis for tests for cardiovascular disease (CVD) that use biomarkers, including: - Worldwide Cardiovascular Disease Biomarkers ...

  • Immunodiagnostics
  • In Vitro Diagnostics
  • United States
  • Company
  • Roche Group

The Market and Potential for Molecular Point of Care Diagnostics

  • $ 4200
  • February 2016
  • 361 pages

Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such ...

  • Diagnostics
  • In Vitro Diagnostics
  • Infectious Disease
  • United States
  • World



Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on